346 related articles for article (PubMed ID: 16881422)
1. Effectiveness of 400 or 600 micrograms of vaginal misoprostol for terminations of early pregnancies.
Ruangchainikhom W; Phongphissanou E; Bhekasuta J; Sarapak S
J Med Assoc Thai; 2006 Jul; 89(7):928-33. PubMed ID: 16881422
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
Herabutya Y; Chanrachakul B; Punyavachira P
BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
Tang OS; Lau WN; Chan CC; Ho PC
BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
[TBL] [Abstract][Full Text] [Related]
4. Success rate of second-trimester termination of pregnancy using misoprostol.
Prachasilpchai N; Russameecharoen K; Borriboonhirunsarn D
J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
[TBL] [Abstract][Full Text] [Related]
5. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
[TBL] [Abstract][Full Text] [Related]
6. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
8. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
[TBL] [Abstract][Full Text] [Related]
9. Second trimester pregnancy termination with 800 mcg vaginal misoprostol.
Pongsatha S; Tongsong T
J Med Assoc Thai; 2001 Jun; 84(6):859-63. PubMed ID: 11556466
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
11. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
[TBL] [Abstract][Full Text] [Related]
12. Termination of second-trimester pregnancy with intracervicovaginal misoprostol.
Srisomboon J; Tongsong T; Pongpisuttinun S
J Med Assoc Thai; 1997 Apr; 80(4):242-6. PubMed ID: 9175393
[TBL] [Abstract][Full Text] [Related]
13. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
Ho PC; Ngai SW; Liu KL; Wong GC; Lee SW
Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
[TBL] [Abstract][Full Text] [Related]
14. Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial.
Carbonell JL; Velazco A; Rodriguez Y; Tanda R; Sánchez C; Barambio S; Valera L; Chami S; Valero F; Aragón S; Marí J
Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):134-40. PubMed ID: 11763976
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
17. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
Singh K; Fong YF; Dong F
BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
[TBL] [Abstract][Full Text] [Related]
18. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
[TBL] [Abstract][Full Text] [Related]
19. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
Ramsey PS; Savage K; Lincoln T; Owen J
Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
